Free Trial
NASDAQ:ALGN

Align Technology (ALGN) Stock Price, News & Analysis

Align Technology logo
$202.28 -2.20 (-1.08%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$202.31 +0.03 (+0.02%)
As of 07/11/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Align Technology Stock (NASDAQ:ALGN)

Key Stats

Today's Range
$200.76
$203.85
50-Day Range
$170.80
$204.48
52-Week Range
$141.74
$263.24
Volume
793,190 shs
Average Volume
919,536 shs
Market Capitalization
$14.66 billion
P/E Ratio
36.85
Dividend Yield
N/A
Price Target
$242.92
Consensus Rating
Moderate Buy

Company Overview

Align Technology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

ALGN MarketRank™: 

Align Technology scored higher than 93% of companies evaluated by MarketBeat, and ranked 83rd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Align Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 9 buy ratings, 4 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Align Technology has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Align Technology's stock forecast and price target.
  • Earnings Growth

    Earnings for Align Technology are expected to grow by 12.16% in the coming year, from $7.98 to $8.95 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Align Technology is 36.85, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Align Technology is 36.85, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.26.

  • Price to Earnings Growth Ratio

    Align Technology has a PEG Ratio of 2.14. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Align Technology has a P/B Ratio of 3.92. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Align Technology's valuation and earnings.
  • Percentage of Shares Shorted

    4.14% of the float of Align Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Align Technology has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Align Technology has recently decreased by 6.95%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Align Technology does not currently pay a dividend.

  • Dividend Growth

    Align Technology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.14% of the float of Align Technology has been sold short.
  • Short Interest Ratio / Days to Cover

    Align Technology has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Align Technology has recently decreased by 6.95%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Align Technology has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Align Technology this week, compared to 14 articles on an average week.
  • Search Interest

    Only 3 people have searched for ALGN on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Align Technology to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Align Technology insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.66% of the stock of Align Technology is held by insiders.

  • Percentage Held by Institutions

    88.43% of the stock of Align Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Align Technology's insider trading history.
Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

ALGN Stock News Headlines

Align Technology (NASDAQ:ALGN) Price Target Raised to $220.00
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
ALGN - Align Technology Inc Trailing Returns - Morningstar
ALGN Stock Price Quote - Morningstar
Reviewing Align Technology (NASDAQ:ALGN) & Endologix (OTCMKTS:ELGXQ)
See More Headlines

ALGN Stock Analysis - Frequently Asked Questions

Align Technology's stock was trading at $208.51 at the beginning of the year. Since then, ALGN shares have decreased by 3.0% and is now trading at $202.28.

Align Technology, Inc. (NASDAQ:ALGN) issued its earnings results on Wednesday, April, 30th. The medical equipment provider reported $2.13 earnings per share for the quarter, beating analysts' consensus estimates of $2.00 by $0.13. The firm's revenue was down 1.8% compared to the same quarter last year.
Read the conference call transcript
.

Align Technology's board approved a stock buyback plan on Tuesday, May 6th 2025, which authorizes the company to repurchase $1,000,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 7.9% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's board believes its shares are undervalued.

Align Technology subsidiaries include exocad Global Holdings GmbH (“exocad”), G.L. Dental Couture, Cadent, and Align Technology Switzerland GmbH.

Align Technology's top institutional shareholders include Swedbank AB (0.58%), Assenagon Asset Management S.A. (0.04%), Czech National Bank (0.02%) and IFM Investors Pty Ltd (0.02%). Insiders that own company stock include Joseph M Hogan, Joseph Lacob, Warren S Thaler, C Raymond Larkin Jr, Kevin J Dallas, John Morici and Emory Wright.
View institutional ownership trends
.

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Align Technology investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Visa (V) and PayPal (PYPL).

Company Calendar

Last Earnings
4/30/2025
Today
7/13/2025
Next Earnings (Confirmed)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ALGN
CIK
1097149
Employees
20,945
Year Founded
1997

Price Target and Rating

High Price Target
$280.00
Low Price Target
$170.00
Potential Upside/Downside
+20.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
$5.49
Trailing P/E Ratio
36.85
Forward P/E Ratio
25.35
P/E Growth
2.14
Net Income
$421.36 million
Net Margins
10.29%
Pretax Margin
14.85%
Return on Equity
13.52%
Return on Assets
8.36%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.21
Quick Ratio
1.08

Sales & Book Value

Annual Sales
$3.98 billion
Price / Sales
3.68
Cash Flow
$8.99 per share
Price / Cash Flow
22.50
Book Value
$51.60 per share
Price / Book
3.92

Miscellaneous

Outstanding Shares
72,485,000
Free Float
72,007,000
Market Cap
$14.66 billion
Optionable
Optionable
Beta
1.63

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ALGN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners